These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 7540276)

  • 21. Evaluation of the Abbott system in maternal serum screening for Down syndrome: the AxSym analyzer, AFP and hCG reagents and Maciel Prenatal Interpretive Software.
    Muller F; Ngo S; Aegerter P; Le Bourdellès S; Taguel V; Rebiffé M; Faïna S; Giraudet P
    Clin Chim Acta; 1998 Sep; 277(1):65-75. PubMed ID: 9776046
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Maternal serum triple analyte screening and adverse pregnancy outcome.
    Milunsky A; Nebiolo L
    Fetal Diagn Ther; 1996; 11(4):249-53. PubMed ID: 8823604
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Replacing Alpha-Fetoprotein With Alpha-Fetoprotein-L3 Increases the Sensitivity of Prenatal Screening for Trisomy 21.
    Huai L; Leng J; Ma S; Huang F; Shen J; Ding Y
    Am J Ther; 2016; 23(6):e1754-e1757. PubMed ID: 26938756
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Elevated maternal urine level of beta-core fragment of human chorionic gonadotropin versus serum triple test in the second-trimester detection of down syndrome.
    Bahado-Singh R; Oz U; Rinne K; Hunter D; Cole L; Mahoney MJ; Baumgarten A
    Am J Obstet Gynecol; 1999 Oct; 181(4):929-33. PubMed ID: 10521756
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Outcome validation of the Beckman Coulter access analyzer in a second-trimester Down syndrome serum screening application.
    MacRae AR; Gardner HA; Allen LC; Tokmakejian S; Lepage N
    Clin Chem; 2003 Jan; 49(1):69-76. PubMed ID: 12507962
    [TBL] [Abstract][Full Text] [Related]  

  • 26. First trimester biochemical screening for trisomy 21: the role of free beta hCG, alpha fetoprotein and pregnancy associated plasma protein A.
    Spencer K; Aitken DA; Crossley JA; McCaw G; Berry E; Anderson R; Connor JM; Macri JN
    Ann Clin Biochem; 1994 Sep; 31 ( Pt 5)():447-54. PubMed ID: 7530437
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cigarette smoking and levels of maternal serum alpha-fetoprotein, unconjugated estriol, and hCG: impact on Down syndrome screening.
    Palomaki GE; Knight GJ; Haddow JE; Canick JA; Wald NJ; Kennard A
    Obstet Gynecol; 1993 May; 81(5 ( Pt 1)):675-8. PubMed ID: 7682315
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Unexplained elevated midtrimester maternal serum levels of alpha fetoprotein, human chorionic gonadotropin, or low unconjugated estriol: recurrence risk and association with adverse perinatal outcome.
    Wax JR; Lopes AM; Benn PA; Lerer T; Steinfeld JD; Ingardia CJ
    J Matern Fetal Med; 2000; 9(3):161-4. PubMed ID: 10914623
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Second-trimester maternal serum screening using alpha-fetoprotein, human chorionic gonadotrophin, and unconjugated oestriol: experience of a regional programme.
    Goodburn SF; Yates JR; Raggatt PR; Carr C; Ferguson-Smith ME; Kershaw AJ; Milton PJ; Ferguson-Smith MA
    Prenat Diagn; 1994 May; 14(5):391-402. PubMed ID: 7521964
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Second trimester prenatal screening for Down's syndrome using alpha-fetoprotein and free beta hCG: a seven year review.
    Spencer K
    Br J Obstet Gynaecol; 1999 Dec; 106(12):1287-93. PubMed ID: 10609723
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Second-trimester maternal serum screening for Down's syndrome: free beta-human chorionic gonadotrophin (HCG) and alpha-fetoprotein, with or without unconjugated oestriol, compared with total HCG, alpha-fetoprotein and unconjugated oestriol.
    Extermann P; Bischof P; Marguerat P; Mermillod B
    Hum Reprod; 1998 Jan; 13(1):220-3. PubMed ID: 9512261
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Second-trimester maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated oestriol after early transvaginal multifetal pregnancy reduction.
    Groutz A; Amit A; Yaron Y; Yovel I; Wolman I; Legum C; Lessing JB
    Prenat Diagn; 1996 Aug; 16(8):723-7. PubMed ID: 8878282
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prenatal screening for fetal aneuploidy in singleton pregnancies.
    Chitayat D; Langlois S; Douglas Wilson R; ;
    J Obstet Gynaecol Can; 2011 Jul; 33(7):736-750. PubMed ID: 21749752
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Second-trimester double or triple screening for Down syndrome: a comparison of Chinese and Caucasian populations.
    Wang YY; Luo J; Zhu MW; Liu LN; Ma X
    Int J Gynaecol Obstet; 2006 Jul; 94(1):67-72. PubMed ID: 16806218
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Second-trimester diurnal variation of maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated oestriol: is it present and does it affect the prediction of a patient's risk for fetal Down syndrome?
    Rose NC; Canick JA; Knight GJ; Pulkkinen A; Tumber MB; Mennuti MT; Palomaki GE
    Prenat Diagn; 1994 Oct; 14(10):947-51. PubMed ID: 7534924
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Second-trimester maternal serum screening for Down syndrome in in vitro fertilization pregnancies.
    Rice JD; McIntosh SF; Halstead AC
    Prenat Diagn; 2005 Mar; 25(3):234-8. PubMed ID: 15791658
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Practical strategies in contingent sequential screening for Down syndrome.
    Benn P; Wright D; Cuckle H
    Prenat Diagn; 2005 Aug; 25(8):645-52. PubMed ID: 16049988
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The value of maternal first and second trimester serum data of β-hCG, PAPP-A, AFP and uE3 in the prediction of preeclampsia].
    Gu W; Lin J; Hou Y
    Zhonghua Fu Chan Ke Za Zhi; 2015 Feb; 50(2):101-7. PubMed ID: 25877605
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cross-trimester repeated measures testing for Down's syndrome screening: an assessment.
    Wright D; Bradbury I; Malone F; D'Alton M; Summers A; Huang T; Ball S; Baker A; Nix B; Aitken D; Crossley J; Cuckle H; Spencer K
    Health Technol Assess; 2010 Jul; 14(33):1-80. PubMed ID: 20624355
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Second trimester maternal serum analytes in triploid pregnancies: correlation with phenotype and sex chromosome complement.
    Benn PA; Gainey A; Ingardia CJ; Rodis JF; Egan JF
    Prenat Diagn; 2001 Aug; 21(8):680-6. PubMed ID: 11536271
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.